Back to search

Physical interaction between dendritic cells and tumor cells results in an immunogen that induces protective and therapeutic tumor rejection.

Data up to Jan 2025

Published1998
Citations179
References29

Total Citations Per Year

Abstract

References (29)

Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor.

1992 • 3,751 citations

Proliferating dendritic cell progenitors in human blood.

1994 • 1,922 citations

Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells

1996 • 1,908 citations

Role of Bone Marrow-Derived Cells in Presenting MHC Class I-Restricted Tumor Antigens

1994 • 1,185 citations

Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity

1995 • 1,097 citations

DNA–based immunization by in vivo transfection of dendritic cells

1996 • 849 citations

A Mechanism for the Specific Immunogenicity of Heat Shock Protein-Chaperoned Peptides

1995 • 838 citations

Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity.

1996 • 746 citations

Manual of clinical immunology

1976 • 726 citations

Induction of antitumor activity by immunization with fusions of dendritic and carcinoma cells

1997 • 596 citations

A new foreign policy: MHC class I molecules monitor the outside world

1996 • 422 citations

Cell Biology of Antigen Processing and Presentation to Major Histocompatibility Complex Class I Molecule-Restricted T Lymphocytes

1992 • 373 citations

Induction of antitumor immunity using bone marrow-generated dendritic cells.

1996 • 323 citations

Dendritic Cells in Antitumor Immune Responses

1996 • 282 citations

Targeting antigen into the phagocytic pathway in vivo induces protective tumour immunity

1995 • 279 citations

Processing of engulfed apoptotic bodies yields T cell epitopes.

1997 • 267 citations

MHC Class I–Restricted CTL Responses to Exogenous Antigens

1996 • 265 citations

CTL induction by a tumour-associated antigen octapeptide derived from a murine lung carcinoma

1994 • 254 citations

Cytokine enhancement of DNA immunization leads to effective treatment of established pulmonary metastases.

1996 • 245 citations

Dendritic Cells in Antitumor Immune Responses

1996 • 219 citations

Accessory cell-T lymphocyte interactions. Antigen-dependent and -independent clustering.

1986 • 205 citations

Dendritic cells and immune-based therapies.

1996 • 180 citations

Effective Tumor Vaccine Generated by Fusion of Hepatoma Cells with Activated B Cells

1994 • 154 citations

Dendritic Cells as Carriers for a Cytotoxic T-Lymphocyte Epitope-Based Peptide Vaccine in Protection Against a Human Papillomavirus Type 16-Induced Tumor

1995 • 131 citations

Dendritic Cells: Antigen Presentation, Accessory Function and Clinical Relevance

1993 • 124 citations

The transporters associated with antigen presentation

1993 • 118 citations

A carcinoembryonic antigen polynucleotide vaccine has in vivo antitumor activity.

1995 • 117 citations

Human Tumor Antigens Are Ready to Fly

1996 • 85 citations

Generation of class I MHC-restricted T-T hybridomas.

1990 • 85 citations

Cited By (0)

No citing papers found in database

Physical interaction between dendritic cells and tumor cells results in an immunogen that… (1998) – PubMed | Metascience Observatory Explorer